| Dr Neil A Brickman, MD | |
|
6900 Orchard Lake Rd, Ste 306, West Bloomfield, MI 48322-3405 | |
| (248) 855-6663 | |
| (248) 855-7546 |
| Full Name | Dr Neil A Brickman |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 6900 Orchard Lake Rd, West Bloomfield, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518952894 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301061722 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Beaumont Hospital - Farmington Hills | Farmington hills, MI | Hospital |
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michigan Healthcare Professionals Pc | 0345413258 | 448 |
News Archive
Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene. In an article receiving Online First publication in the New England Journal of Medicine to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study participants and suppressed tumor growth in another 9.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has entered into definitive agreements with certain new and existing accredited investors providing for a private placement of common stock and warrants in which the Company will receive $24 million in gross proceeds.
NexMed, Inc., backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced that the Israel Patent Office has issued an allowance notice for NexMed's patent application entitled, "Topical Compositions for Prostaglandin E1 Delivery."
Researchers at Mount Sinai School of Medicine for the first time have determined that bone marrow cells play a critical role in fighting respiratory viruses, making the bone marrow a potential therapeutic target, especially in people with compromised immune systems. They have found that during infections of the respiratory tract, cells produced by the bone marrow are instructed by proteins to migrate to the lungs to help fight infection. The data are published in the current issue of Cell Host & Microbe.
› Verified 9 days ago
| Entity Name | Michigan Healthcare Professionals Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295023547 PECOS PAC ID: 0345413258 Enrollment ID: O20111109000027 |
News Archive
Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene. In an article receiving Online First publication in the New England Journal of Medicine to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study participants and suppressed tumor growth in another 9.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has entered into definitive agreements with certain new and existing accredited investors providing for a private placement of common stock and warrants in which the Company will receive $24 million in gross proceeds.
NexMed, Inc., backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced that the Israel Patent Office has issued an allowance notice for NexMed's patent application entitled, "Topical Compositions for Prostaglandin E1 Delivery."
Researchers at Mount Sinai School of Medicine for the first time have determined that bone marrow cells play a critical role in fighting respiratory viruses, making the bone marrow a potential therapeutic target, especially in people with compromised immune systems. They have found that during infections of the respiratory tract, cells produced by the bone marrow are instructed by proteins to migrate to the lungs to help fight infection. The data are published in the current issue of Cell Host & Microbe.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Neil A Brickman, MD 6900 Orchard Lake Rd, Ste 306, West Bloomfield, MI 48322-3405 Ph: (248) 855-6663 | Dr Neil A Brickman, MD 6900 Orchard Lake Rd, Ste 306, West Bloomfield, MI 48322-3405 Ph: (248) 855-6663 |
News Archive
Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene. In an article receiving Online First publication in the New England Journal of Medicine to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study participants and suppressed tumor growth in another 9.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has entered into definitive agreements with certain new and existing accredited investors providing for a private placement of common stock and warrants in which the Company will receive $24 million in gross proceeds.
NexMed, Inc., backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced that the Israel Patent Office has issued an allowance notice for NexMed's patent application entitled, "Topical Compositions for Prostaglandin E1 Delivery."
Researchers at Mount Sinai School of Medicine for the first time have determined that bone marrow cells play a critical role in fighting respiratory viruses, making the bone marrow a potential therapeutic target, especially in people with compromised immune systems. They have found that during infections of the respiratory tract, cells produced by the bone marrow are instructed by proteins to migrate to the lungs to help fight infection. The data are published in the current issue of Cell Host & Microbe.
› Verified 9 days ago
Dr. Rachel Mary O'keefe, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2300 Haggerty Rd, Suite 2070, West Bloomfield, MI 48323 Phone: 248-926-2020 Fax: 248-926-9020 | |
Dr. Deborah A Charfoos, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6900 Orchard Lake Rd, Ste 306, West Bloomfield, MI 48322 Phone: 248-855-6663 Fax: 248-855-7546 | |
Robert Lorenz, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3226 Wellington Ct, West Bloomfield, MI 48324 Phone: 248-417-1946 | |
Dr. Michael Charles Kent, D.O. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2485 Doleman Dr, West Bloomfield, MI 48324 Phone: 248-681-6550 | |
Robert S. Goldfarb, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 6777 West Maple Road, West Bloomfield, MI 48323 Phone: 248-661-6450 Fax: 248-661-6649 | |
Kwabena Appiah, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: Henry Ford Health System, 6777 West Maple Road, West Bloomfield, MI 48323 Phone: 248-661-6450 Fax: 248-661-6649 | |
Dr. Shalom Mazaki-tovi, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5858 Fineway Ct, West Bloomfield, MI 48322 Phone: 248-419-0885 |